Your request to link to rcsb for Albumin
- 1E78: crystal structure of human serum albumin (10.1074/JBC.M005460200 )
- 1E7A: crystal structure of human serum albumin complexed with the general anesthetic propofol (10.1074/JBC.M005460200 )
- 1E7B: crystal structure of human serum albumin complexed with the general anesthetic halothane (10.1074/JBC.M005460200 )
- 1E7C: human serum albumin complexed with myristic acid and the general anesthetic halothane (10.1074/JBC.M005460200 )
- 1E7E: human serum albumin complexed with decanoic acid (capric acid) (10.1006/JMBI.2000.4158 )
- 1E7F: human serum albumin complexed with dodecanoic acid (lauric acid) (10.1006/JMBI.2000.4158 )
- 1E7G: human serum albumin complexed with tetradecanoic acid (myristic acid) (10.1006/JMBI.2000.4158 )
- 1E7H: human serum albumin complexed with hexadecanoic acid (palmitic acid) (10.1006/JMBI.2000.4158 )
- 1E7I: human serum albumin complexed with octadecanoic acid (stearic acid) (10.1006/JMBI.2000.4158 )
- 1GNI: human serum albumin complexed with cis-9-octadecenoic acid (oleic acid) (10.1006/JMBI.2000.5208 )
- 1GNJ: human serum albumin complexed with cis-5,8,11,14-eicosatetraenoic acid (arachidonic acid) (10.1006/JMBI.2000.5208 )
- 1H9Z: human serum albumin complexed with myristic acid and the r-(+) enantiomer of warfarin (10.1074/JBC.M100575200 )
- 1HA2: human serum albumin complexed with myristic acid and the s-(-) enantiomer of warfarin (10.1074/JBC.M100575200 )
- 1HK1: human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-l- thyronine) (10.1073/PNAS.1137188100 )
- 1HK2: human serum albumin mutant r218h complexed with thyroxine (3,3',5,5'- tetraiodo-l-thyronine) (10.1073/PNAS.1137188100 )
- 1HK3: human serum albumin mutant r218p complexed with thyroxine (3,3',5,5'- tetraiodo-l-thyronine) (10.1073/PNAS.1137188100 )
- 1HK4: human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) and myristic acid (tetradecanoic acid) (10.1073/PNAS.1137188100 )
- 1HK5: human serum albumin mutant r218h complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) and myristic acid (tetradecanoic acid) (10.1073/PNAS.1137188100 )
- 1N5U: x-ray study of human serum albumin complexed with heme (10.1006/BBRC.2002.6540 )
- 1O9X: human serum albumin complexed with tetradecanoic acid (myristic acid) and hemin (10.1186/1472-6807-3-6 )
- 1TF0: crystal structure of the ga module complexed with human serum albumin (10.1074/JBC.M406957200 )
- 1UOR: x-ray study of recombinant human serum albumin. phases determined by molecular replacement method, using low resolution structure model of tetragonal form of human serum albumin (10.1038/358209A0 )
- 1YSX: solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand directed against bcl- xl and bcl-2 (10.1038/NATURE03579 )
- 2BX8: human serum albumin complexed with azapropazone (10.1016/J.JMB.2005.07.075 )
- 2BXA: human serum albumin complexed with 3-carboxy-4-methyl-5- propyl-2-furanpropanoic acid (cmpf) (10.1016/J.JMB.2005.07.075 )
- 2BXB: human serum albumin complexed with oxyphenbutazone (10.1016/J.JMB.2005.07.075 )
- 2BXC: human serum albumin complexed with phenylbutazone (10.1016/J.JMB.2005.07.075 )
- 2BXD: human serum albumin complexed with warfarin (10.1016/J.JMB.2005.07.075 )
- 2BXE: human serum albumin complexed with diflunisal (10.1016/J.JMB.2005.07.075 )
- 2BXF: human serum albumin complexed with diazepam (10.1016/J.JMB.2005.07.075 )
- 2BXG: human serum albumin complexed with ibuprofen (10.1016/J.JMB.2005.07.075 )
- 2BXH: human serum albumin complexed with indoxyl sulfate (10.1016/J.JMB.2005.07.075 )
- 2BXI: human serum albumin complexed with myristate and azapropazone (10.1016/J.JMB.2005.07.075 )
- 2BXK: human serum albumin complexed with myristate, azapropazone and indomethacin (10.1016/J.JMB.2005.07.075 )
- 2BXL: human serum albumin complexed with myristate and 3,5- diiodosalicylic acid (10.1016/J.JMB.2005.07.075 )
- 2BXM: human serum albumin complexed with myristate and indomethacin (10.1016/J.JMB.2005.07.075 )
- 2BXN: human serum albumin complexed with myristate and iodipamide (10.1016/J.JMB.2005.07.075 )
- 2BXO: human serum albumin complexed with myristate and oxyphenbutazone (10.1016/J.JMB.2005.07.075 )
- 2BXP: human serum albumin complexed with myristate and phenylbutazone (10.1016/J.JMB.2005.07.075 )
- 2BXQ: human serum albumin complexed with myristate, phenylbutazone and indomethacin (10.1016/J.JMB.2005.07.075 )
- 2ESG: solution structure of the complex between immunoglobulin iga1 and human serum albumin (10.1016/J.JMB.2005.11.060 )
- 2I2Z: human serum albumin complexed with myristate and aspirin (10.1016/J.JSB.2006.08.015 )
- 2I30: human serum albumin complexed with myristate and salicylic acid (10.1016/J.JSB.2006.08.015 )
- 2VDB: structure of human serum albumin with s-naproxen and the ga module (10.1107/S174430910706770X )
- 2VUE: human serum albumin complexed with 4z,15e-bilirubin-ix-alpha (10.1016/J.JMB.2008.06.016 )
- 2VUF: human serum albumin complexed with fusidic acid (10.1016/J.JMB.2008.06.016 )
- 2XSI: human serum albumin complexed with dansyl-l-glutamate and myristic acid (10.1016/J.JSB.2010.10.004 )
- 2XVQ: human serum albumin complexed with dansyl-l-sarcosine (10.1016/J.JSB.2010.10.004 )
- 2XVU: human serum albumin complexed with dansyl-l-asparagine (10.1016/J.JSB.2010.10.004 )
- 2XVV: human serum albumin complexed with dansyl-l-asparagine and myristic acid (10.1016/J.JSB.2010.10.004 )
- 2XVW: human serum albumin complexed with dansyl-l-arginine and myristic acid (10.1016/J.JSB.2010.10.004 )
- 2XW0: human serum albumin complexed with dansyl-l-phenylalanine (10.1016/J.JSB.2010.10.004 )
- 2XW1: human serum albumin complexed with dansyl-l-norvaline (10.1016/J.JSB.2010.10.004 )
- 2YDF: human serum albumin complexed with iophenoxic acid (10.1186/1472-6807-11-18 )
- 3A73: crystal structure analysis of human serum albumin complexed with delta 12-prostaglandin j2 (10.1021/JA908878N )
- 3B9L: human serum albumin complexed with myristate and azt (10.1016/J.JSB.2007.12.004 )
- 3B9M: human serum albumin complexed with myristate, 3'-azido-3'- deoxythymidine (azt) and salicylic acid (10.1016/J.JSB.2007.12.004 )
- 3CX9: crystal structure of human serum albumin complexed with myristic acid and lysophosphatidylethanolamine (10.1042/BJ20090913 )
- 3JQZ: crystal structure of human serum albumin complexed with lidocaine (10.1016/J.JSB.2010.03.014 )
- 3JRY: human serum albumin with bound sulfate (10.1016/J.JSB.2010.03.014 )
- 3LU6: human serum albumin in complex with compound 1 (10.1016/J.BMC.2010.08.052 )
- 3LU7: human serum albumin in complex with compound 2 (10.1016/J.BMC.2010.08.052 )
- 3LU8: human serum albumin in complex with compound 3 (10.1016/J.BMC.2010.08.052 )
- 3SQJ: recombinant human serum albumin from transgenic plant (10.1073/PNAS.1109736108 )
- 3TDL: structure of human serum albumin in complex with dauda (10.1002/PRO.749 )
- 3UIV: human serum albumin-myristate-amantadine hydrochloride complex
- 4BKE: recombinant human serum albumin with palmitic acid. synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site ii of human serum albumin (10.1186/1472-6807-14-4 )
- 4E99: human serum albumin complex with perfluorooctane sulfonate potassium (10.1021/TX300112P )
- 4EMX: crystal structure analysis of human serum albumin in complex with chloride anions at cryogenic temperature
- 4G03: high-resolution crystal structural variance analysis between recombinant and wild-type human serum albumin
- 4G04: high-resolution crystal structural variance analysis between recombinant and wild-type human serum albumin
- 4HGK: shark ignar variable domain (10.1074/JBC.M112.435289 )
- 4HGM: shark ignar variable domain (10.1074/JBC.M112.435289 )
- 4IW1: hsa-fructose complex (10.1074/JBC.M113.467027 )
- 4IW2: hsa-glucose complex (10.1074/JBC.M113.467027 )
- 4K2C: hsa ligand free (10.1074/JBC.M113.467027 )
- 4K71: crystal structure of a high affinity human serum albumin variant bound to the neonatal fc receptor (10.1016/J.STR.2013.08.022 )
- 4L8U: x-ray study of human serum albumin complexed with 9 amino camptothecin (10.1016/J.BBAGEN.2013.06.032 )
- 4L9K: x-ray study of human serum albumin complexed with camptothecin (10.1016/J.BBAGEN.2013.06.032 )
- 4L9Q: x-ray study of human serum albumin complexed with teniposide (10.1016/J.BBAGEN.2013.06.032 )
- 4LA0: x-ray study of human serum albumin complexed with bicalutamide (10.1016/J.BBAGEN.2013.06.032 )
- 4LB2: x-ray study of human serum albumin complexed with idarubicin (10.1016/J.BBAGEN.2013.06.032 )
- 4LB9: x-ray study of human serum albumin complexed with etoposide (10.1016/J.BBAGEN.2013.06.032 )
- 4N0F: human fcrn complexed with human serum albumin (10.1074/JBC.M113.537563 )
- 4N0U: ternary complex between neonatal fc receptor, serum albumin and fc (10.1074/JBC.M113.537563 )
- 4S1Y: x-ray structure of human serum albumin complexed with cisplatin (10.1039/C5CC01751C )
- 4Z69: human serum albumin complexed with palmitic acid and diclofenac (10.1111/CBDD.12583 )
- 5FUO: extending the half-life of a fab fragment through generation of a humanised anti-human serum albumin (hsa) fv domain: an investigation into the correlation between affinity and serum half-life (10.1080/19420862.2016.1185581 )
- 5GIX: human serum albumin-palmitic acid-fe(hn3pit)cl2 (10.1021/ACS.JMEDCHEM.6B00509 )
- 5GIY: hsa-palmitic acid-[rucl5(ind)]2-
- 5ID7: crystal structure of human serum albumin in complex with phosphorodithioate derivative of myristoyl cyclic phosphatidic acid (cpa) (10.1042/BSR20160089 )
- 5IFO: x-ray structure of hsa-myr-kp1019 (10.1021/ACS.JMEDCHEM.6B00600 )
- 5IJF: crystal structure of human serum albumin in the presence of 0.5 mm zinc at ph 9.0 (10.1039/C6SC02267G )
- 5UJB: structure of a mcl-1 inhibitor binding to site 3 of human serum albumin (10.1016/J.BMC.2017.03.060 )
- 5VNW: crystal structure of nb.b201 bound to human serum albumin (10.1038/S41594-018-0028-6 )
- 5X52: human serum albumin complexed with octanoate and n-acetyl-l-methionine (10.1016/J.BBAPAP.2017.04.004 )
- 5YB1: structure and function of human serum albumin-metal agent complex (10.1021/ACS.MOLPHARMACEUT.8B00045 )
- 5YOQ: human serum albumin complexed with sodium 4-phenylbutyrate (10.1016/J.BBREP.2018.01.006 )
- 5Z0B: crystal structure of plasma-derived human serum albumin
- 6A7P: human serum albumin complexed with aripiprazole (10.1021/ACSOMEGA.8B02057 )
- 6EZQ: human serum albumin complexed with nbd-c12 fatty acid (10.1002/ANIE.201710437 )
- 6HSC: structure of human serum albumin in complex with aristolochic acid at 1.9 a resolution
- 6JE7: crystal structure of human serum albumin crystallized by ammonium sulfate (10.1021/ACS.CGD.9B00256 )
- 6L4K: human serum albumin-palmitic acid-cu compound
- 6M4R: structure of human serum albumin
- 6M58: crystal structure of a complex between human serum albumin and the antibody fab sl335 (10.1016/J.BBRC.2020.03.133 )
- 6M5D: human serum albumin (apo form) (10.1021/ACS.JMEDCHEM.0C01578 )
- 6M5E: human serum albumin with cyclic peptide dalbavancin (10.1021/ACS.JMEDCHEM.0C01578 )
- 6QIO: ternary complex of fcrn ectodomain, fcrn binding optimised human serum albumin and the human growth hormone derivative somapacitan (10.1021/ACS.BIOCHEM.0C00019 )
- 6QIP: ternary complex of fcrn ectodomain, fcrn binding optimised human serum albumin and the albumin-biniding side chain of the human growth hormone derivative somapacitan (10.1021/ACS.BIOCHEM.0C00019 )
- 6R7S: human serum albumin, complexed with sulfasalazine (10.1002/CMDC.202000069 )
- 6WUW: crystal structure of human serum albumin complex with jms-053 (10.1124/MOLPHARM.120.000131 )
- 6XV0: lauric acid functionalized hexamolybdoaluminate bound to human serum albumin (10.1021/ACS.INORGCHEM.9B03407 )
- 6YG9: crystal structure of human serum albumin (hsa) in complex with gn-07. (10.1002/ADVS.202002997 )
- 6ZL1: crystal structure of human serum albumin in complex with the mcl-1 neutralizing alphabody cmpx-383b (10.1126/SCIADV.ABE1682 )
- 7D6J: human serum albumin complexed with benzbromarone (10.1021/ACS.MOLPHARMACEUT.0C01004 )
- 7DJN: human serum albumin
- 7DL4: crystal structure of human serum albumin and nitrosylruthenium complex adduct
- 7EEK: structure of human serum albumin-au compound complex
- 7JWN: crystal structure of human serum albumin in complex with ketoprofen
- 7QFE: crystal structure of human serum albumin in complex with gemfibrozil (10.3390/IJMS23031769 )
- 7VR9: crystal structure of human serum albumin complex with aripiprazole and myristic acid (10.1021/ACSOMEGA.1C06220 )